OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2025
(1)
2024
(1)
2023
(1)
2017
(1)
2016
(1)
2015
(1)
2014
(1)
2013
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Effectiveness of indacaterol/glycopyrronium/mometasone for refractory asthmatic cough after switching from inhaled corticosteroid/long-acting β<sub>2</sub>-agonist therapy.
Not available
S-EPMC12528903
|
biostudies-literature
Cite
Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.
Not available
S-EPMC4019829
|
biostudies-literature
Cite
The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study.
Not available
S-EPMC4588424
|
biostudies-literature
Cite
Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls.
Not available
S-EPMC10400628
|
biostudies-literature
Cite
Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.
Not available
S-EPMC5506236
|
biostudies-literature
Cite
Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial.
Not available
S-EPMC4709460
|
biostudies-literature
Cite
SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians.
Not available
S-EPMC3614978
|
biostudies-literature
Cite
Polygenic effects on the risk of Alzheimer's disease in the Japanese population.
Not available
S-EPMC10898021
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets